...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >PRESCRIPTION PATTERN OF DRUGS USED IN THE TREATMENT OF PEPTIC ULCER DISEASE IN THE DEPARTMENT OF GASTROENTEROLOGY IN A TERTIARY CARE HOSPITAL
【24h】

PRESCRIPTION PATTERN OF DRUGS USED IN THE TREATMENT OF PEPTIC ULCER DISEASE IN THE DEPARTMENT OF GASTROENTEROLOGY IN A TERTIARY CARE HOSPITAL

机译:三级医院消化科消化道溃疡用药的处方

获取原文
   

获取外文期刊封面封底 >>

       

摘要

For more than a century Peptic Ulcer Disease (PUD) has been considered to be a major cause of morbidity and mortality. Most first line treatment for PUD involves use of acid suppressing drugs and target against the eradication of Helicobacter pylori (H. pylori) infection. However, the treatment strategy employed in India is not well studied. Hence, this study aims to provide insight into the prescription pattern of drugs used in PUD in India. The data was extracted from the medical records of all patients diagnosed with PUD from June 2011 to May 2012. A retrospective analysis was done to study the prescribing pattern of the drugs. The data was noted down on a pre-designed proforma and analysed. Records of 200 patients were assessed. About 91% of patients were prescribed anti H. pylori kit and the most commonly prescribed kit being Esomeprazole H.P kit (59.7%) followed by Pantoprazole H P kit. Following this, all patients were started on Proton pump inhibitors (PPI) for duration of about 6.89±2.25 weeks. On the basis of present study it was found that eradication of H. pylori is considered to be the most important treatment strategy in the management of PUD in India. Esomeprazole based HP kit was preferred, since several studies have shown them to be more efficacious. This was followed by a course of PPI to prevent recurrence.
机译:一个多世纪以来,消化性溃疡疾病(PUD)被认为是发病率和死亡率的主要原因。 PUD的大多数一线治疗都涉及使用酸抑制药物,并且目标是根除幽门螺杆菌(H. pylori)感染。但是,在印度采用的治疗策略尚未得到充分研究。因此,本研究旨在深入了解印度PUD中所用药物的处方模式。该数据摘自2011年6月至2012年5月所有诊断为PUD的患者的病历。进行了回顾性分析,以研究药物的处方方式。将数据记录在预先设计的形式表中并进行分析。评估了200名患者的记录。约有91%的患者开了抗幽门螺杆菌药盒,最常用的药盒是艾美拉唑H.P药盒(59.7%),然后是Pantoprazole H P药盒。此后,所有患者均开始接受质子泵抑制剂(PPI),治疗时间约6.89±2.25周。根据目前的研究,发现根除幽门螺杆菌被认为是印度PUD管理中最重要的治疗策略。首选基于埃索美拉唑的HP试剂盒,因为多项研究表明它们更有效。随后进行一系列PPI预防复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号